Dezhan Healthcare Ties Up With CAE's Academician Yang Baofeng to Set Up Drug-Developing Workstation

MT NewswiresDec 19 03:47 ET

Dezhan Healthcare (000813.SZ): Signed a cooperation framework agreement with Academician Yang Baofeng from the Chinese Academy of Engineering.

On December 18, Gelonghui announced that Dezhan Healthcare (000813.SZ) has been established to further enhance the research and innovation capabilities of Dezhan Healthcare Co., Ltd. (hereinafter referred to as "the company"), build a high-level research and innovation system, improve the efficiency of research and innovation, accelerate the conversion of technological achievements, and provide strong intellectual support and technical guarantee for the sustainable development of the company. On December 17, 2024, the company signed a "Cooperation Framework Agreement" with Academician Yang Baofeng from the Chinese Academy of Engineering to jointly conduct research and development of pharmaceuticals and health products in various fields such as cardiovascular and cerebrovascular diseases, cancer, metabolic system diseases, pulmonary hypertension, and neurological and mental disorders.

Gelonghui FinanceDec 18 06:59 ET

Dezhan Healthcare Company Limited (SZSE:000813) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Simply Wall StDec 12 17:56 ET

dezhan healthcare (000813.SZ): Shanghai Yueye's 19.13% stake in the company is planned to be auctioned.

Dezhan Healthcare (000813.SZ) issued an announcement that the company received shares held at 5... on November 27, 2024.

Zhitong FinanceNov 27 04:45 ET

Dezhan Healthcare (000813.SZ): Did not cooperate with the viral marketing agency.

Gelonghui November 14th, dezhan healthcare (000813.SZ) stated on the investor interaction platform that the company is currently not cooperating with explosive advertising companies.

Gelonghui FinanceNov 14 02:36 ET

dezhan healthcare (000813.SZ): The accumulated repurchased 1.16% of shares.

Healthcare Dezhan (000813.SZ) announced on November 4th that, as of October 31, 2024, the company has repurchased a total of 25,037,500 shares of the company through a stock repurchase special securities account by means of centralized competitive bidding trading, accounting for 1.16% of the company's current total share capital. The highest fill price was 3.03 yuan/share, the lowest fill price was 2.39 yuan/share, with a total transaction amount of 62,550,587.00 yuan (excluding trading fees).

Gelonghui FinanceNov 4 03:50 ET